Blood tests during anabolic steroid use can identify changes in blood counts, liver markers, kidney function, cholesterol and selected hormones. The choice of tests depends on symptoms, substances, medical history and the question being asked. Results need clinical interpretation: a normal panel does not establish that continued use is safe.
If someone has collapsed, cannot breathe normally or cannot stay safe, seek emergency help. Do not wait for a routine blood test or an online interpretation.
Which tests might a clinician consider?
Assessment starts with a conversation and examination, including blood pressure. A clinician can then select tests, compare previous results and arrange followup. The NSW Health clinical resource describes this broader approach. Buying the largest available panel is not a substitute for deciding which clinical questions need answers.
| Test or assessment | What it can help assess | What it cannot settle alone |
|---|---|---|
| Blood count during anabolic steroid use | Haemoglobin and haematocrit changes. | A raised count does not diagnose a clot. |
| Liver markers during anabolic steroid use | Patterns involving enzymes and bilirubin. | One normal enzyme does not exclude liver injury. |
| Kidney blood tests and urine albumin during anabolic steroid use | Filtration estimates, electrolytes and albumin leakage. | Creatinine alone can mislead in muscular people. |
| Lipids and blood pressure | Cardiovascular risk factors. | Neither measures heart structure or rhythm. |
| Glucose and HbA1c | Current glucose or its longer term pattern. | An average cannot exclude a sudden low glucose episode. |
| Selected reproductive hormones | Hormone exposure and recovery in context. | Blood testosterone does not establish sperm production. |
This page covers test selection and interpretation. The anabolic steroid side effects overview brings together the wider health concerns. The individual organ articles below explain their own conditions in more detail.
When should testing happen?
Testing before exposure may document existing problems, but it cannot predict a safe response to a future product. During use, testing may investigate symptoms or track a known abnormality. After stopping, a clinician may assess persistent effects or recovery. The timing should follow the clinical problem, earlier findings and the substances involved; symptoms can change that plan immediately.
Prescribed testosterone has product instructions and clinical monitoring recommendations for a defined treatment. For example, the XYOSTED prescribing information specifies periodic haematocrit assessment. That does not validate the same timetable for nonmedical combinations, uncertain products or much larger exposures. Tell the prescriber about all additional products so monitoring can reflect the full exposure.
Ask who will review the results, when you should expect contact and what to do if the result does not arrive. A repeat test may confirm an unexpected finding or follow a trend; an urgent abnormality may require action before any repeat. Do not assume that no message means every result was normal.
What do haemoglobin and haematocrit show?
Haemoglobin is the oxygen carrying protein in red blood cells. Haematocrit is the proportion of blood occupied by those cells. A full blood count, also called a complete blood count, measures these alongside other blood components. Laboratory units and reference intervals can differ, so bring the full report rather than an isolated number. MedlinePlus explains the haematocrit test.
Anabolic steroids can increase red cell production. Fluid loss can also concentrate blood, while smoking, reduced oxygen and other disorders can contribute to a raised count. A clinician may need to distinguish these causes. An abnormal count is neither proof of a vein clot nor permission to ignore clot symptoms. NHS information on erythrocytosis describes assessment of different causes.
Do not use blood donation, self bleeding, aspirin or anticoagulants as a way to make steroid use safe. Treatment depends on the cause and clinical circumstances; removing blood can reduce iron stores and has its own risks. Research has not established routine blood removal as a safe solution for testosterone related erythrocytosis. See the 2024 review of testosterone and phlebotomy and our article on haematocrit and blood clots.
How are liver results interpreted?
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) can rise with tissue injury, but AST is also present in muscle. Alkaline phosphatase (ALP), gamma glutamyl transferase (GGT) and bilirubin help clinicians examine other patterns. Albumin and clotting tests may answer different questions about liver function. Interpretation depends on the combination, symptoms and trend, as described by the NHS Specialist Pharmacy Service.
Recent strenuous exercise can raise AST and ALT. A small experiment in 15 healthy men found prolonged enzyme elevations after weightlifting. This supports recording exercise before a sample; it does not establish that an abnormal result in a steroid user comes from training. The clinician decides if repeat sampling, muscle tests or further investigation is appropriate. The weightlifting study examined a specific exercise setting.
Some anabolic steroids, particularly certain oral compounds, can cause impaired bile flow with marked jaundice despite comparatively modest enzyme changes. Rare structural problems are another reason that a normal panel cannot exclude every liver complication. The LiverTox androgen record describes these patterns. Yellow eyes or skin need prompt assessment, not an assumption that the enzyme results are reassuring. Our liver damage article covers the conditions and care pathways.
Why can kidney blood tests be difficult to interpret?
Creatinine is influenced by muscle mass as well as kidney filtration. Creatine supplements, recent meat intake and vigorous exercise can affect interpretation. Estimated glomerular filtration rate (eGFR) calculated from creatinine may need further assessment in a muscular person. An elevated creatinine must not be dismissed as a training effect without clinical review. MedlinePlus describes creatinine testing and its limitations.
Urine albumin to creatinine ratio (ACR) can identify albumin leakage that a blood test alone misses. Cystatin C can help in selected circumstances, but it also has influences unrelated to filtration; anabolic hormone exposure complicates choosing the best estimate. A clinician may use a combined estimate or further testing. The KDIGO 2024 recommendations address these distinctions.
Kidney assessment may include electrolytes, blood pressure, urine findings and changes from prior results. Chronic kidney disease requires evidence of persistence, generally at least three months; suspected acute injury needs timely assessment now. That chronicity definition is not an instruction to wait three months after a sudden deterioration. See anabolic steroids and kidney damage.
What do cholesterol and glucose results add?
A lipid panel measures cholesterol fractions and triglycerides. Results contribute to cardiovascular assessment alongside blood pressure, smoking, diabetes, age and medical history. A cholesterol result does not show the heart’s pumping function, detect every rhythm problem or rule out an acute heart attack. Symptoms and examination may justify other investigations. MedlinePlus describes cholesterol testing.
In a prospective study of 100 men using androgens, blood pressure rose and lipid results shifted unfavourably during exposure, including lower high density lipoprotein (HDL) cholesterol and higher low density lipoprotein (LDL) cholesterol. Group recovery after stopping did not establish that an individual had avoided cardiovascular injury. The 2022 prospective study had limited followup for cardiovascular outcomes.
Glucose testing measures blood sugar at the sampling time. Glycated haemoglobin (HbA1c) reflects roughly the previous three months and may help assess longer term glucose patterns. It cannot exclude a sudden low or high glucose episode. Recent blood loss, transfusion, altered red cell survival or iron deficiency can change its interpretation. A raised haematocrit alone is not enough to conclude that HbA1c is inaccurate. The NIDDK explanation of HbA1c describes these limitations.
Tell the clinician about insulin, growth hormone and all diabetes medicines as well as anabolic steroids. These exposures can affect the questions that glucose testing needs to answer. Testosterone product information also notes possible changes in glucose control and insulin requirements. Do not adjust prescribed diabetes treatment from an online result; contact your diabetes team and follow your agreed care plan.
What can hormone tests tell you during and after use?
Testosterone, luteinising hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (SHBG) may help answer selected questions. External androgens can suppress LH and FSH. Blood testosterone can be high, normal or low depending on the compounds and sampling context; a testosterone assay does not measure every synthetic androgen. A result during use cannot simply be read as the body’s untreated hormone production. Anawalt’s clinical review explains these differing patterns.
Record the last exposure, product formulation and any medicines used after stopping. Recovery assessment differs from interpreting results during ongoing use. Estradiol or other hormone tests may be useful for particular symptoms, but broad testing without a clinical question can produce confusing findings. A single result should not determine a self prescribed hormone or recovery regimen.
When a clinician investigates suspected testosterone deficiency, symptoms and appropriately repeated measurements are relevant. The Endocrine Society recommendations concern diagnosis and prescribed treatment; they are not a clearance system for nonmedical use. Blood testosterone also does not establish fertility. Semen testing answers a different question, and sperm recovery may lag hormone recovery. Our male fertility article explains that assessment.
Which additional checks depend on the person?
A recent RACGP clinical article published in September 2026 includes targeted assessments beyond a basic blood panel. Pregnancy testing can be relevant if pregnancy is possible; discuss a positive result and exposure promptly with a clinician. Infection testing may be indicated by shared injecting equipment or sexual exposure. Fertility concerns may justify semen analysis. These are decisions for the individual, not a universal list that everyone needs to purchase.
Human immunodeficiency virus (HIV), hepatitis B and hepatitis C testing can involve exposure timing and followup. After a recent possible HIV exposure, including shared needles, seek assessment immediately: preventive treatment must start within 72 hours and works best when started sooner. Do not wait for a routine panel. The CDC advice on care after HIV exposure explains the urgency.
Prostate specific antigen (PSA) testing may be discussed for prostate symptoms or an individual screening decision. An elevated result does not diagnose cancer: benign enlargement, inflammation and some other factors can affect it. The benefits and possible harms of screening need discussion. The National Cancer Institute explains PSA testing.
Blood pressure measurement, a physical examination and questions about sleep, mood, sexual function and injection sites remain relevant even with normal blood results. Selected cardiac tests or specialist referrals may follow symptoms or findings. Routine chemistry testing cannot establish mental wellbeing, exclude dependence or verify the contents of an unregulated product.
How can you make the appointment and results more useful?
- Bring the full previous reports, including dates, units and reference intervals.
- List product names, formulations, route, approximate exposure dates and the most recent dose. Say if the contents are uncertain.
- Include prescribed medicines, recovery drugs, insulin, growth hormone, supplements, alcohol and other substances.
- Describe symptoms, their timing, recent illness, exercise, fluid loss and any blood donation.
- Explain your main concern, such as a new symptom, an abnormal result, stopping use or fertility.
Follow the laboratory’s instructions. Ask if fasting or a particular sampling time is needed; neither is universal. Tell the clinician about supplements, including biotin, which can interfere with some assays, and ask if any could interfere with the planned assay. Do not stop prescribed medicines or alter exposure merely to make a result look different. If you could not follow the instructions, tell the laboratory. MedlinePlus explains test preparation.
A reference interval is a comparison with a reference population, not a personalised safe exposure boundary. Healthy people can sometimes have results outside it, and illness can be present despite a result inside it. Trends, symptoms and the reason for testing help determine the next step. MedlinePlus explains laboratory result interpretation.
Ask: What finding needs action? What needs a repeat, and why? Is another type of assessment needed? Who will arrange it? Keep the agreed followup date and contact details with your report. Our article on talking to a doctor about steroid use can help you prepare that conversation.